ADAR1 Capital Management, LLC 13D/13G Filings for Kala Pharmaceuticals, Inc. (KALA)

ADAR1 Capital Management, LLC 13D and 13G filings for Kala Pharmaceuticals, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2025-02-14
9:04 pm
Sale		 2024-12-31 13G Kala Pharmaceuticals, Inc.
KALA		 ADAR1 Capital Management, LLC 298,955
4.910%		 -181,476decrease
(-37.77%)		 Filing
2024-11-14
4:49 pm
Purchase		 2024-09-30 13G Kala Pharmaceuticals, Inc.
KALA		 ADAR1 Capital Management, LLC 480,431
9.990%		 480,431increase
(New Position)		 Filing